Brief: Kane Biotech announces removal of all debt from its balance sheet and grant of options
24/07/2017 23:00
July 24 (Reuters) - Kane Biotech Inc KNE.V
* Kane Biotech announces removal of all debt from its
balance sheet and grant of options
* Kane Biotech Inc says it has paid out all its outstanding
debt
Source text for Eikon: ID:nCCNGXs41a
Further company coverage: KNE.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update